Incyte
INCY
#1110
Rank
NZ$34.83 B
Marketcap
NZ$177.46
Share price
2.05%
Change (1 day)
39.33%
Change (1 year)

Incyte (INCY) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$8.05 Billion

According to Incyte's latest financial reports the company has NZ$8.05 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Incyte - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$6.11 B-25.51%
2023-12-31$NZ$8.20 B19.23%
2022-12-31$NZ$6.88 B24.71%
2021-12-31$NZ$5.51 B52.51%
2020-12-31$NZ$3.61 B-6.2%
2019-12-31$NZ$3.85 B34.37%
2018-12-31$NZ$2.87 B25.05%
2017-12-31$NZ$2.29 B279.15%
2016-12-31$NZ$0.60 B142.15%
2015-12-31$NZ$0.25 B-340.04%
2014-12-31$-NZ$0.11 Billion-55.67%
2013-12-31$-NZ$0.24 Billion10.49%
2012-12-31$-NZ$0.22 Billion-26.9%
2011-12-31$-NZ$0.3 Billion153.22%
2010-12-31$-NZ$0.12 Billion-18.49%
2009-12-31$-NZ$0.15 Billion-62.94%
2008-12-31$-NZ$0.39 Billion82.66%
2007-12-31$-NZ$0.21 Billion72.79%
2006-12-31$-NZ$0.13 Billion324.69%
2005-12-31$-NZ$28.38 Million-125.79%
2004-12-31$NZ$0.11 B-53.65%
2003-12-31$NZ$0.23 B-58.91%
2002-12-31$NZ$0.57 B-45.49%
2001-12-31$NZ$1.06 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Amgen
AMGN
NZ$16.65 B 106.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$1.64 B-79.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$41.28 B 412.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$161.14 B 1,901.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
NZ$0.43 B-94.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
NZ$0.26 B-96.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$77.46 B 862.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
NZ$49.93 M-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-NZ$43.88 Million-100.54%๐Ÿ‡บ๐Ÿ‡ธ USA